Biological
Autologous Cytokine-induced Killer Cells clinical trials
- studies test it
- 17
- open now
- 4
- in phase 3
- 5
- first study started
- 2008
Keep track of what changes. Save the Autologous Cytokine-induced Killer Cells studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2015 (5)
| Year | Studies |
|---|---|
| 2008 | 3 |
| 2009 | 1 |
| 2013 | 2 |
| 2015 | 5 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 5
- Phase 2
- 8
- Phase 3
- 5
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 9
GC Cell Corporation (7) · The First People's Hospital of Changzhou (2) · Seoul National University Hospital (1) · Chinese PLA General Hospital (1) · Sun Yat-sen University (1) · Royan Institute (1) · Henan Cancer Hospital (1) · Tianjin Medical University Cancer Institute and Hospital (1)
Often tested with
Tested in the same studies.
Temozolomide (2) · Adoptive Immunotherapy (1) · Sintilimab (1)
Studies
Open first, then newest update. How each study uses Autologous Cytokine-induced Killer Cells is read from its arms, and is right about nine times in ten.
Testing it · 17
- Safety and Feasibility of CIK Cell Therapy in HCC After Tumor ResectionNot yet recruitingEarly Phase 1Royan InstituteNCT07709299Written as Autologous Cytokine-Induced Killer (CIK) Cells
- Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic CancerRecruitingPhase 3GC Cell CorporationNCT04969731Written as Immuncell-LC
- Effect of Cytokine-induced Killer Cells for Advanced Malignant GliomasNot yet recruitingPhase 4The First People's Hospital of ChangzhouNCT02496988Written as CIK
- Effect of Cytokine-induced Killer Cells for Stage I-II Malignant GliomasNot yet recruitingPhase 1/2The First People's Hospital of ChangzhouNCT02494804Written as CIK
- Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of KoreaCompletedPhase 3GC Cell CorporationNCT00807027Written as Activated T lymphocyte(Immuncell-LC)
- Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic CancerCompletedPhase 2GC Cell CorporationNCT00965718Written as Activated T lymphocyte
- Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma PatientsCompletedPhase 3GC Cell CorporationNCT00699816Written as Immuncell-LC
- Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCCCompletedPhase 2GC Cell CorporationNCT01897610Written as Immuncell-LC
- Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver TransplantationCompletedPhase 1/2GC Cell CorporationNCT03983967Written as Immuncell-LC
- Safety and Efficacy of "Immuncell-LC" in TACE TherapyCompletedPhase 2GC Cell CorporationNCT02856815Written as Immuncell-LC
- Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung AdenocarcinomaTerminatedPhase 2Henan Cancer HospitalNCT02621333Written as CIK
- Study of Autologous CIK Cell Immunotherapy Combination With PD-1 Inhibitor and Chemotherapy in the Advanced NSCLCStatus unknownPhase 1Tianjin Medical University Cancer Institute and HospitalNCT03987867Written as CIK cell
- Safety and Efficacy of γδ T Cell Against Gastric CancerStatus unknownPhase 1/2Beijing Doing Biomedical Co., Ltd.NCT02585908Written as CIK
- A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed NeuroblastomaCompletedNot applicableSeoul National University HospitalNCT01802138Written as Activated T lymphocyte
- Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe PsoriasisCompletedPhase 1/2Chinese PLA General HospitalNCT01894373Written as CIK
- Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCCStatus unknownPhase 3Sherief Abd-ElsalamNCT02568748Written as CIK
- Study of Cytokine-induced Killer Cell (CIK) Treatment in Patients After Resection of Liver CancerCompletedPhase 3Sun Yat-sen UniversityNCT00769106Written as cytokine-induced killer cell (CIK) treatment